Shames Richard S. 4
4 · Protagonist Therapeutics, Inc · Filed Sep 12, 2017
Insider Transaction Report
Form 4
Shame Richard S
Chief Medical Officer
Transactions
- Sale
Common Stock
2017-09-12$14.31/sh−3,687$52,753→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017.
- [F2]Includes 1,822 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 8, 2017.
- [F3]The shares were sold at prices ranging from $14.251 to $14.3443. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.